VTCN1 抗体
(V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
This gene encodes a protein belonging to the B7 costimulatory protein family. Proteins in this family are present on the surface of antigen-presenting cells and interact with ligand bound to receptors on the surface of T cells. Studies have shown that high levels of the encoded protein has been correlated with tumor progression. A pseudogene of this gene is located on chromosome 20. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| VTCN1 抗体 (CF®740) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (CF®568) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (CF®647) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (CF®640R) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (CF®488A) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (CF®594) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (Biotin) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (CF®640R) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (CF®405S) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (CF®647) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (CF®740) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (CF®568) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant VTCN1 抗体 (Internal Region) | 人 | 兔 Monoclonal |
|
|
|
| VTCN1 抗体 (AA 25-259) | 人 | 兔 Polyclonal |
|
|
|
| VTCN1 抗体 (PerCP) | 人 | Human Monoclonal |
|
|
|
| VTCN1 抗体 (FITC) | 人 | 小鼠 Monoclonal |
|
|
|
| VTCN1 抗体 (PE) | 人 | Human Monoclonal |
|
|
|
| VTCN1 抗体 (FITC) | 人 | Human Monoclonal |
|
|
|
| VTCN1 抗体 (APC) | 人 | Human Monoclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- B7H4-1788
- 标记
- CF®740
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- B7H4-1788
- 标记
- CF®568
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- B7H4-1788
- 标记
- CF®647
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- B7H4-1788
- 标记
- CF®640R
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VISTA-3007
- 标记
- CF®488A
- 抗体亚型
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VISTA-3007
- 标记
- CF®594
- 抗体亚型
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VISTA-3007
- 标记
- Biotin
- 抗体亚型
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VISTA-3007
- 标记
- CF®640R
- 抗体亚型
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VISTA-3007
- 标记
- CF®405S
- 抗体亚型
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VISTA-3007
- 标记
- CF®647
- 抗体亚型
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VISTA-3007
- 标记
- CF®740
- 抗体亚型
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VISTA-3007
- 标记
- CF®568
- 抗体亚型
- IgG2b, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- RM525
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 25-259
Primary Antibody
- 适用
- 人
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- ABS0181
- 标记
- PerCP
- 抗体亚型
- IgG1, kappa
Primary Antibody
- 适用
- 人
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- ABS0181
- 标记
- FITC
- 抗体亚型
- IgG1, kappa
Latest Publications for our VTCN1 抗体
: "The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma." in: Journal of cancer research and clinical oncology, (2022) (PubMed).
: "Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 23, Issue 12, pp. 2934-2941, (2018) (PubMed).
: "Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer." in: Oncology letters, Vol. 11, Issue 4, pp. 2815-2819, (2016) (PubMed).
: "Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 196, Issue 4, pp. 1495-506, (2016) (PubMed).
: "Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients." in: Oncotarget, Vol. 7, Issue 47, pp. 77237-77243, (2016) (PubMed).
: "Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis." in: Tumour biology, (2014) (PubMed).
: "B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 8, pp. 4165-74, (2012) (PubMed).
: "Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 6, pp. 3054-63, (2012) (PubMed).
: "Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation." in: Blood, Vol. 118, Issue 9, pp. 2502-10, (2011) (PubMed).
: "B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 49, pp. 19458-63, (2007) (PubMed).
: "Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 23, Issue 12, pp. 2934-2941, (2018) (PubMed).
: "Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer." in: Oncology letters, Vol. 11, Issue 4, pp. 2815-2819, (2016) (PubMed).
: "Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 196, Issue 4, pp. 1495-506, (2016) (PubMed).
: "Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients." in: Oncotarget, Vol. 7, Issue 47, pp. 77237-77243, (2016) (PubMed).
: "Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis." in: Tumour biology, (2014) (PubMed).
: "B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 8, pp. 4165-74, (2012) (PubMed).
: "Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 6, pp. 3054-63, (2012) (PubMed).
: "Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation." in: Blood, Vol. 118, Issue 9, pp. 2502-10, (2011) (PubMed).
: "B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 49, pp. 19458-63, (2007) (PubMed).
Aliases for VTCN1 抗体
V set domain containing T cell activation inhibitor 1 L homeolog (vtcn1.L) 抗体V-set domain containing T cell activation inhibitor 1 (VTCN1) 抗体
V-set domain containing T-cell activation inhibitor 1 (VTCN1) 抗体
V set domain containing T cell activation inhibitor 1 (vtcn1) 抗体
V-set domain containing T cell activation inhibitor 1 (Vtcn1) 抗体
B7-H4 抗体
B7h.5 抗体
B7h4 抗体
B7H4 抗体
B7s1 抗体
B7S1 抗体
B7x 抗体
B7X 抗体
BC032925 抗体
PRO1291 抗体
RGD1311204 抗体
VCTN1 抗体
您还需要查找其他产品吗？
You are here:
